Chronic stress–induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci195685 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Yongkang Wu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Biology, School of Basic Medical Sciences. Hauptthemen laut MEDLINE: Ferroptosis, Liver Neoplasms, Glutathione, Stress, Physiological. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Science Foundation of China.
Abstract (Originalsprache)
Emerging evidence demonstrates that chronic stress alters immunological, neurochemical, and endocrinological functions, thereby promoting tumor progression. However, the underlying metabolic mechanism of chronic stress in tumor progression is still elusive. Using multiomics analysis, we found that aminopeptidase N (ANPEP) was upregulated in tumors with chronic restraint, associating with the reprogramming of amino acid metabolism. Functional assays revealed that ANPEP promoted liver cancer growth and metastasis. Knockdown of ANPEP blocked chronic stress–induced liver cancer progression. Chronic stress–induced glucocorticoids promoted nuclear receptor subfamily 3 group C member 1 nuclear translocation to activate ANPEP transcription by directly binding to its promoter. Furthermore, ANPEP promotes glutathione synthesis, subsequently inhibiting ROS-induced ferroptosis. Mechanistically, ANPEP interacted with solute carrier family 3 member 2 (SLC3A2) to block membrane associated ring-CH-type finger 8–mediated lysosome-dependent degradation of SLC3A2, promoting intracellular l-cystine transport, thereby increasing glutathione synthesis. The combination of ANPEP silencing and sorafenib treatment showed a synergistic effect in inhibiting liver cancer progression. Finally, clinical data and mouse models demonstrated that chronic stress drove liver tumor progression via ANPEP-regulated SLC3A2. These findings reveal unanticipated communication between chronic stress and metabolic reprogramming during liver cancer progression, providing potential therapeutic implications for liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular Biology, School of Basic Medical Sciences.
- Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, School of Basic Medical Sciences; and.
- Key Laboratory for Experimental Teratology of the Ministry of Education, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo Medical College, Shandong University, Jinan, China.
Förderung
- the National Science Foundation of China
Zitieren
APA
Wu, Y., Zhang, Y., Shi, X., Wu, M., Sun, M., Feng, Y., Ma, W., Jiang, X., Fei, D., Zhao, M., Wu, Z., Li, C., Liang, X., Gao, L., Ma, C., & Yue, X. (2026). Chronic stress–induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis. Journal of Clinical Investigation. https://doi.org/10.1172/jci195685
Vancouver
Wu Y, Zhang Y, Shi X, Wu M, Sun M, Feng Y, et al. Chronic stress–induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis. Journal of Clinical Investigation. 2026. doi:10.1172/jci195685
BibTeX
@article{Wu2026,
author = {Wu, Yongkang and Zhang, Yankun and Shi, Xiaojia and Wu, Mengting and Sun, Min and Feng, Ying and Ma, Wenmeng and Jiang, Xiule and Fei, Dingqi and Zhao, Mingjian and Wu, Zhuanchang and Li, Chunyang and Liang, Xiaohong and Gao, Lifen and Ma, Chunhong and Yue, Xuetian},
title = {Chronic stress–induced ANPEP drives liver cancer progression by increasing glutathione synthesis and inhibiting ferroptosis},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci195685}
}
EUVIMED